VERTEX PHARMACEUTICALS INC / MA Increase (Decrease) in Other Noncurrent Assets
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Increase (Decrease) in Other Noncurrent Assets of $92.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2014-11-06
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in other noncurrent assets for the quarter ending 2014-09-30 was -$436.00K.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in other noncurrent assets for the quarter ending 2014-06-30 was $52.00K, a 10.34% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in other noncurrent assets for the quarter ending 2014-03-31 was $476.00K.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in other noncurrent assets for the quarter ending 2013-09-30 was -$680.00K, a 232.81% decline year-over-year.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month |
|---|---|---|---|
| 2014-09-30 | -$436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$384.00K derived: sum of 2 quarters · filed 2014-11-06 | $92.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $528.00K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $476.00K 10-Q · filed 2014-05-05 | ||
| 2013-09-30 | -$680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$622.00K derived: sum of 2 quarters · filed 2014-11-06 | -$1.09M 10-Q · filed 2014-11-06 |
| 2013-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$414.00K 10-Q · filed 2014-07-31 | |
| 2013-03-31 | -$472.00K 10-Q · filed 2014-05-05 | ||
| 2012-09-30 | $512.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $997.00K 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $485.00K 10-Q · filed 2013-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |